Green Planet Bio Engineering Co. Ltd. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Green Planet Bio Engineering Co. Ltd. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($35.8K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($35.5K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($47.7K) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($32.5K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($32.9K) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($33.6K) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($25.4K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($40.2K) | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | ($33.8K) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($35.7K) | Mar 8, 2018 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($36.5K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($35.0K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($42.7K) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($32.5K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($32.9K) | Mar 30, 2023 |
| FY2020 | Dec 31, 2020 | ($33.8K) | Mar 31, 2021 |
| FY2020 | Dec 31, 2019 | ($36.9K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($40.2K) | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | $0 | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $0 | Mar 8, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $257.5K | Mar 1, 2019 |
| FY2018 | Dec 31, 2017 | $217.3K | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $183.4K | Mar 8, 2018 |
| FY2016 | Dec 31, 2015 | $147.8K | Mar 10, 2017 |
| FY2015 | Dec 31, 2014 | $114.7K | Mar 30, 2016 |
| FY2014 | Dec 31, 2013 | $77.2K | Mar 31, 2015 |
| FY2013 | Dec 31, 2012 | $42.8K | Apr 15, 2014 |
| FY2012 | Dec 31, 2011 | $178.6K | Apr 16, 2013 |
| FY2011 | Dec 31, 2010 | $160.4K | Apr 3, 2012 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($501.0K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($465.1K) | Mar 31, 2026 |
| FY2025 | Dec 31, 2023 | ($429.6K) | Mar 31, 2026 |
| FY2024 | Dec 31, 2022 | ($381.9K) | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | ($349.4K) | Mar 29, 2024 |
| FY2022 | Dec 31, 2020 | ($316.5K) | Mar 30, 2023 |
| FY2021 | Dec 31, 2019 | ($282.9K) | Mar 14, 2022 |
| FY2020 | Dec 31, 2018 | ($257.5K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | ($217.3K) | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | ($183.4K) | Mar 1, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.13M) | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | ($1.09M) | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | ($1.06M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($1.01M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($979.0K) | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | ($946.1K) | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | ($912.5K) | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | ($887.1K) | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | ($846.9K) | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | ($813.0K) | Mar 8, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2022 | $0 | Mar 30, 2023 |
| FY2022 | Dec 31, 2021 | $0 | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | $0 | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | $0 | Mar 31, 2021 |
| FY2020 | Dec 31, 2018 | $0 | Mar 31, 2021 |
| FY2019 | Dec 31, 2017 | $0 | Mar 11, 2020 |
| FY2018 | Dec 31, 2016 | $0 | Mar 1, 2019 |
| FY2017 | Dec 31, 2015 | $0 | Mar 8, 2018 |
| FY2016 | Dec 31, 2014 | $0 | Mar 10, 2017 |
| FY2015 | Dec 31, 2013 | $0 | Mar 30, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2011 | Dec 31, 2010 | 0 | Apr 3, 2012 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Mar 7, 2025 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 20.01M | Mar 31, 2026 |
| FY2025 | Dec 31, 2024 | 20.01M | Mar 31, 2026 |
| FY2024 | Dec 31, 2023 | 20.01M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 20.01M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 20.01M | Mar 30, 2023 |
| FY2021 | Dec 31, 2020 | 20.01M | Mar 14, 2022 |
| FY2020 | Dec 31, 2019 | 20.01M | Mar 31, 2021 |
| FY2019 | Dec 31, 2018 | 20.01M | Mar 11, 2020 |
| FY2018 | Dec 31, 2017 | 20.01M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | 20.01M | Mar 8, 2018 |